Mark Hensley
Corporate Officer/Principal at VELOXIS PHARMACEUTICALS A/S
Profile
Mark Hensley is currently working as the Chief Commercial Officer at Veloxis Pharmaceuticals A.
He started this position in 2019.
Mr. Hensley completed his undergraduate degree at the University of North Texas.
Mark Hensley active positions
| Companies | Position | Start |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | 2019-01-02 |
Training of Mark Hensley
| University of North Texas | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Stock Market
- Insiders
- Mark Hensley
